spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

PRISYM ID to Exhibit at the Clinical Trials Supply Nordics Event

PRISYM ID

PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6

30th May 2017:  PRISYM ID, leading provider of labelling solutions for the life sciences industries, is exhibiting at The Clinical Trial Supply Event in Copenhagen, Denmark on the 7/8th June 2017, on stand 6.

The 2017 event programme will host a variety of speakers from a number of leading pharmaceutical companies as well as a number of small to mid-sized biotechs. This two-day event will focus on the top issues facing the industry such as label simplification to improve efficiency and cold chain management for safeguarding products. These challenges will be addressed through interactive presentations and engaging panel discussions. There will also be stimulating roundtable discussions on both days, allowing attendees to debate possible solutions in smaller groups.

This is a great opportunity for Clinical Trial organisations to hear more about the latest Clinical Trial Management module update PRISYM ID launched, in addition to its renowned, flagship solution, PRISYM 360, to further transform global Label Lifecycle Management.

Unlike traditional label design tools, PRISYM 360 is an enterprise-class solution designed specifically for, and in partnership with, the life science industry. The addition of its Clinical Trial Management module provides out-of- the-box clinical labelling data structures and tools based on clinical study best practice, allowing clinical research teams to design and print compliant labels quickly and effectively.

The event offers a perfect platform for collaborating and building relationships between attendees and PRISYM ID to facilitate the formation of new partnerships and strengthening existing relationships.

For more information about PRISYM ID and to arrange a meeting during the event, please contact info@prisymid.com or call +44 (0)118 936 4400

About PRISYM ID
World Class Label Management Software
PRISYM ID designs and delivers label management software for organizations that need complete product auto-identification and lifecycle traceability. With the continual tightening of labeling regulations and audits, PRISYM ID empowers its clients to safeguard their reputation by ensuring compliance, removing risk and significantly reduce costs by eliminating recalls through labeling errors. PRISYM ID is the market leader in providing validatable world-class label lifecycle management, and is trusted for delivering personalized service excellence to clients.

http://www.prisymid.com/

phone +44 (0) 118 936 4400
email info@prisymid.com
web www.prisymid.com/
email TECH House, Oaklands Business Centre, Oaklands Park, Wokingham, Berkshire, RG41 2FD, UK
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Source BioScience invest in digital pathology platform to enhance the outsourced histopathology service solution provided to the NHS and private healthcare

As a leading provider of outsourced histopathology services to the NHS and private healthcare centres in the UK Source BioScience has, after a detailed review of all other available alternatives in the digital marketplace, unveiled investment in a digital pathology platform from their preferred partner, Philips.
More info >>


White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement